Results 201 to 210 of about 62,887 (245)

Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studies. [PDF]

ESMO Open
Shitara K, Smyth E, Lordick F, Pophale R, Matney C, Matsangou M, Gourgioti G, Oh M, Ranganath R, Klempner SJ.   +9 more
europepmc   +1 more source

Competing Demographic Drivers of Hospital Expenditures: Coexistence of the Red Herring and the Steepening Effects

Health Economics, EarlyView.
ABSTRACT The fiscal sustainability of healthcare systems is increasingly strained by aging populations with two competing hypotheses dominating the literature. The Red Herring Hypothesis suggests that healthcare expenditures are driven more by proximity to death than by chronological age, while the Steepening Hypothesis examines whether expenditures ...
Malene Kallestrup‐Lamb, Alexander O. K. Marin, Jes Søgaard   +2 more
wiley   +1 more source

Using mixture cure models to address algorithmic bias in diagnostic timing: autism as a test case. [PDF]

JAMIA Open
Wu P, Davis NO, Engelhard MM, Dawson G, Goldstein BA.   +4 more
europepmc   +1 more source

Strategic Delay and Bargaining Over Public Insurance Coverage for Drugs in Australia

Health Economics, EarlyView.
ABSTRACT Public funding for pharmaceuticals often follows repeated negotiation between manufacturers and a public agency, yet little empirical work examines how the timing of agreement reflects the economic structure of these interactions. Using a duration model of negotiations in Australia from 2005 to 2018, we assess whether observed patterns of ...
Jing Jing Li, Anthony Harris
wiley   +1 more source

Comparing IPCW Models to Adjust for Informative Censoring During COVID-19 Using Data From the Clinical Practice Research Datalink. [PDF]

Pharmacoepidemiol Drug Saf
Aubrac G, Webster-Clark M, Platt RW.
europepmc   +1 more source

Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Larynx

Head &Neck, EarlyView.
ABSTRACT Background University of Michigan Cancer Center (UMCC) protocol 9520 treated stage III/IV locally advanced squamous cell carcinoma of the larynx (LASCCL) with cisplatin and 5‐fluorouracil to select for definitive therapy based on response.
Zachary Risch, Emily Bellile, Moneb S. Bughrara, Paul L. Swiecicki, Keith Casper, Kelly Malloy, Norman Hogikyan, Matthew Spector, Andrew Shuman, Chaz Stucken, Steven Chinn, Douglas C. Chepeha, Shruti Jolly, Michelle Mierzwa, Carol Bradford, Avraham Eisbruch, Thomas Carey, Mark Prince, Gregory T. Wolf, Francis P. Worden   +19 more
wiley   +1 more source

Non-Markov Nonparametric Estimation of Complex Multistate Outcomes After Hematopoietic Stem Cell Transplantation. [PDF]

Biom J
Vilsmeier J, Schmeller S, Fürst D, Beyersmann J.   +3 more
europepmc   +1 more source

An alternative method for assessing the fragility of survival analysis results: a proof-of-concept study based on the log-rank test. [PDF]

Am J Epidemiol
Xing X, Xing A, Natarajan K, Chu H, Lin L, Tong J.   +5 more
europepmc   +1 more source

Assessing delayed treatment benefits of immunotherapy using long-term average hazard: a novel test/estimation approach. [PDF]

Lifetime Data Anal
Horiguchi M, Tian L, Kehl KL, Uno H.
europepmc   +1 more source

Comment on 'the impact of body mass index on the efficacy of CDK4/6 inhibitors in patients with metastatic breast cancer'. [PDF]

Ann Med
Chen X, Gu S, Ding S.
europepmc   +1 more source